Virginia Catalyst Begins Round Nine of Grant Funding
Tuesday, August 14, 2018
The Virginia Biosciences Health Research Corporation (VBHRC), known as Virginia Catalyst, is now accepting applications/letters of intent (LOIs) for round nine of grants to fund the development and commercialization of life science projects that address major unmet needs for improving human health.
Virginia Catalyst awards these funds to help accelerate translational research in the Commonwealth of Virginia. The awards, which range from $200,000 to $800,000, help fund collaborative efforts between industry and Virginia research universities with the goal of:
• Funding innovative, collaborative, translational research projects that elevate the level of sponsored research at Virginia’s universities and have the potential to significantly improve human health and create high value jobs in the Commonwealth
• Accelerating commercialization of Virginia research university inventions and discoveries and to achieve competitive critical mass through robust collaborations of Virginia research universities and industry
Letters of intent (LOI) must be received by November 15, 2018 at 5:00 PM EST. Projects that meet criteria will be invited to submit a full application. Awards will be announced in March 2019. The LOI submission form and application template, as well as grant criteria, are available on the Virginia Catalyst website (www.virginiacatalyst.org).
“Virginia’s entrepreneurial spirit continues to inspire our work,” said Mike Grisham, CEO, Virginia Catalyst. “Through the first eight funding rounds, Virginia Catalyst has seen companies and research institutions work together to create high-paying jobs that boost Virginia’s overall economy. These funds help bolster Virginia’s life sciences sector while also developing technologies that tangibly improve citizens’ lives. We look forward to supporting our research investigators and entrepreneurs in achieving milestones that will result in follow-on funding and build sustainable businesses.”